| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-13 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-12 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-12 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.31 | 2e-11 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |